Cellular antioxidant properties of human natural killer enhancing factor B.
The protein, NKEF (natural killer enhancing factor), has been identified as a member of an antioxidant family of proteins capable of protecting against protein oxidation in cell-free assay systems. The mechanism of action for this family of proteins appears to involve scavenging or suppressing formation of protein thiyl radicals. In the present study we investigated the antioxidant protective properties of the NKEF-B protein overexpressed in an endothelial cell line (ECV304). Nkef-B-transfected cells displayed significantly lower levels of reactive oxygen species (ROS) compared with control or vector-transfected cells. Tert-Butylhydroperoxide-induced ROS was 15% lower in nkef-B-transfected cells and cytotoxicity was slightly, though not significantly, lower. NKEF-B had no effect on ROS induced by menadione or xanthine plus xanthine oxidase. NKEF-B overexpression resulted in slightly (approximately 10%) lower levels of cellular glutathione (GSH) and had no effect on rate or extent of GSH depletion following either diethylmaleate (DEM) or buthionine sulfoximine (BSO) treatment. Lipid peroxidation, assessed as thiobarbituric acid-reactive substances, was 40% lower in nkef-B-transfected cells compared with vector-only-transfected cells. DEM-induced lipid peroxidation was suppressed by NKEF-B at DEM concentrations of 20 microM to 1 mM. At 10 mM DEM, lipid peroxidation was unaffected by NKEF-B. NKEF-B expression also protected cells against menadione-induced inhibition of [3H]-thymidine uptake. The NKEF-B protein appears most effective in suppressing basal low-level oxidative injury such as that produced during normal metabolism. These results indicate that overexpression of the NKEF-B protein promotes resistance to oxidative stress in this endothelial cell line.
Sarafian
T A
TA
Department of Pathology, UCLA 90095, USA.
Rajper
N
N
Grigorian
B
B
Kim
A
A
Shau
H
H
D000975:Antioxidants / Q000378:metabolism*; D001798:Blood Proteins / Q000502:physiology*; D016923:Cell Death / Q000502:physiology; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects / Q000502:physiology; D005452:Fluoresceins / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006360:Heat-Shock Proteins; D006801:Humans; D008298:Maleates / Q000494:pharmacology; D010544:Peroxidases; D010545:Peroxides / Q000494:pharmacology; D054464:Peroxiredoxins; D017382:Reactive Oxygen Species / Q000378:metabolism*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D014118:Toxins, Biological / Q000494:pharmacology; D014162:Transfection; D014812:Vitamin K / Q000494:pharmacology; D020122:tert-Butylhydroperoxide
D000975:Antioxidants; D001798:Blood Proteins; D005452:Fluoresceins; D006360:Heat-Shock Proteins; D008298:Maleates; D010545:Peroxides; D017382:Reactive Oxygen Species; D017392:Thiobarbituric Acid Reactive Substances; D014118:Toxins, Biological; D014812:Vitamin K; C029569:diacetyldichlorofluorescein; D020122:tert-Butylhydroperoxide; D010544:Peroxidases; C086065:PRDX2 protein, human; D054464:Peroxiredoxins; C014476:diethyl maleate; D005978:Glutathione